When conventional treatment fails: the role of intravenous immunoglobulin in recurrent pregnancy loss secondary to antiphospholipid syndrome.
- Resource Type
- Case Study
- Authors
- Chay, Jacklyn; Lust, Karin; Kubler, Paul; Callaway, Leonie
- Source
- Obstetric Medicine (1753-495X). Jun2013, Vol. 6 Issue 2, p76-79. 4p. 1 Chart.
- Subject
- *ASPIRIN
*HEPARIN
*THERAPEUTIC use of immunoglobulins
*ANTIPHOSPHOLIPID syndrome
*EVALUATION of medical care
*MISCARRIAGE
*TREATMENT effectiveness
*DISEASE complications
*PREGNANCY
*PREVENTION
- Language
- ISSN
- 1753-495X
The article describes the case of a 31-year-old woman with primary antiphospholipid syndrome (APS) who was able to give successful live birth after undergoing intravenous immunoglobulin (IVIG) therapy. It notes that the woman suffered previous miscarriages while being treated with low-dose aspirin and low-molecular weight heparin (LMWH). It cites the efficacy of IVIG use with heparin/aspirin combination in the management of patients with recurrent pregnancy loss (RPL).